767 related articles for article (PubMed ID: 15667495)
1. Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR.
Malinen E; Rinttilä T; Kajander K; Mättö J; Kassinen A; Krogius L; Saarela M; Korpela R; Palva A
Am J Gastroenterol; 2005 Feb; 100(2):373-82. PubMed ID: 15667495
[TBL] [Abstract][Full Text] [Related]
2. The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects.
Kassinen A; Krogius-Kurikka L; Mäkivuokko H; Rinttilä T; Paulin L; Corander J; Malinen E; Apajalahti J; Palva A
Gastroenterology; 2007 Jul; 133(1):24-33. PubMed ID: 17631127
[TBL] [Abstract][Full Text] [Related]
3. Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome.
Rajilić-Stojanović M; Biagi E; Heilig HG; Kajander K; Kekkonen RA; Tims S; de Vos WM
Gastroenterology; 2011 Nov; 141(5):1792-801. PubMed ID: 21820992
[TBL] [Abstract][Full Text] [Related]
4. Increase in fecal primary bile acids and dysbiosis in patients with diarrhea-predominant irritable bowel syndrome.
Duboc H; Rainteau D; Rajca S; Humbert L; Farabos D; Maubert M; Grondin V; Jouet P; Bouhassira D; Seksik P; Sokol H; Coffin B; Sabaté JM
Neurogastroenterol Motil; 2012 Jun; 24(6):513-20, e246-7. PubMed ID: 22356587
[TBL] [Abstract][Full Text] [Related]
5. An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota.
Jeffery IB; O'Toole PW; Öhman L; Claesson MJ; Deane J; Quigley EM; Simrén M
Gut; 2012 Jul; 61(7):997-1006. PubMed ID: 22180058
[TBL] [Abstract][Full Text] [Related]
6. Fecal Microbiota in Patients with Irritable Bowel Syndrome Compared with Healthy Controls Using Real-Time Polymerase Chain Reaction: An Evidence of Dysbiosis.
Shukla R; Ghoshal U; Dhole TN; Ghoshal UC
Dig Dis Sci; 2015 Oct; 60(10):2953-62. PubMed ID: 25784074
[TBL] [Abstract][Full Text] [Related]
7. The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
Ki Cha B; Mun Jung S; Hwan Choi C; Song ID; Woong Lee H; Joon Kim H; Hyuk J; Kyung Chang S; Kim K; Chung WS; Seo JG
J Clin Gastroenterol; 2012 Mar; 46(3):220-7. PubMed ID: 22157240
[TBL] [Abstract][Full Text] [Related]
8. Functional dysbiosis within the gut microbiota of patients with constipated-irritable bowel syndrome.
Chassard C; Dapoigny M; Scott KP; Crouzet L; Del'homme C; Marquet P; Martin JC; Pickering G; Ardid D; Eschalier A; Dubray C; Flint HJ; Bernalier-Donadille A
Aliment Pharmacol Ther; 2012 Apr; 35(7):828-38. PubMed ID: 22315951
[TBL] [Abstract][Full Text] [Related]
9. Quantitative profiling of gut microbiota of children with diarrhea-predominant irritable bowel syndrome.
Rigsbee L; Agans R; Shankar V; Kenche H; Khamis HJ; Michail S; Paliy O
Am J Gastroenterol; 2012 Nov; 107(11):1740-51. PubMed ID: 22986438
[TBL] [Abstract][Full Text] [Related]
10. [The composition of the gastrointestinal mucosa-associated microbiota in irritable bowel syndrome patients].
Loranskaia ID; Boldyreva MN; Lavrent'eva OA
Eksp Klin Gastroenterol; 2013; (3):15-22. PubMed ID: 24294767
[TBL] [Abstract][Full Text] [Related]
11. Rectal bleeding in infancy: clinical, allergological, and microbiological examination.
Arvola T; Ruuska T; Keränen J; Hyöty H; Salminen S; Isolauri E
Pediatrics; 2006 Apr; 117(4):e760-8. PubMed ID: 16585287
[TBL] [Abstract][Full Text] [Related]
12. Abnormal intestinal permeability in subgroups of diarrhea-predominant irritable bowel syndromes.
Dunlop SP; Hebden J; Campbell E; Naesdal J; Olbe L; Perkins AC; Spiller RC
Am J Gastroenterol; 2006 Jun; 101(6):1288-94. PubMed ID: 16771951
[TBL] [Abstract][Full Text] [Related]
13. A pilot study of fecal serine-protease activity: a pathophysiologic factor in diarrhea-predominant irritable bowel syndrome.
Róka R; Rosztóczy A; Leveque M; Izbéki F; Nagy F; Molnár T; Lonovics J; Garcia-Villar R; Fioramonti J; Wittmann T; Bueno L
Clin Gastroenterol Hepatol; 2007 May; 5(5):550-5. PubMed ID: 17336590
[TBL] [Abstract][Full Text] [Related]
14. Distinct microbial populations exist in the mucosa-associated microbiota of sub-groups of irritable bowel syndrome.
Parkes GC; Rayment NB; Hudspith BN; Petrovska L; Lomer MC; Brostoff J; Whelan K; Sanderson JD
Neurogastroenterol Motil; 2012 Jan; 24(1):31-9. PubMed ID: 22070725
[TBL] [Abstract][Full Text] [Related]
15. The expression and the cellular distribution of the tight junction proteins are altered in irritable bowel syndrome patients with differences according to the disease subtype.
Bertiaux-Vandaële N; Youmba SB; Belmonte L; Lecleire S; Antonietti M; Gourcerol G; Leroi AM; Déchelotte P; Ménard JF; Ducrotté P; Coëffier M
Am J Gastroenterol; 2011 Dec; 106(12):2165-73. PubMed ID: 22008894
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the alternating bowel habit subtype in patients with irritable bowel syndrome.
Tillisch K; Labus JS; Naliboff BD; Bolus R; Shetzline M; Mayer EA; Chang L
Am J Gastroenterol; 2005 Apr; 100(4):896-904. PubMed ID: 15784038
[TBL] [Abstract][Full Text] [Related]
17. Identification of an Intestinal Microbiota Signature Associated With Severity of Irritable Bowel Syndrome.
Tap J; Derrien M; Törnblom H; Brazeilles R; Cools-Portier S; Doré J; Störsrud S; Le Nevé B; Öhman L; Simrén M
Gastroenterology; 2017 Jan; 152(1):111-123.e8. PubMed ID: 27725146
[TBL] [Abstract][Full Text] [Related]
18. [Serum serotonin concentration and urine 5-hydroxyindole acetic acid excretion in patients with irritable bowel syndrome].
Moskwa A; Chojnacki J; Wiśiewska-Jarosińska M; Stec-Michalska K; Szadkowski K; Smigielski J; Chojnacki C
Pol Merkur Lekarski; 2007 May; 22(131):366-8. PubMed ID: 17679369
[TBL] [Abstract][Full Text] [Related]
19. Altered profiles of intestinal microbiota and organic acids may be the origin of symptoms in irritable bowel syndrome.
Tana C; Umesaki Y; Imaoka A; Handa T; Kanazawa M; Fukudo S
Neurogastroenterol Motil; 2010 May; 22(5):512-9, e114-5. PubMed ID: 19903265
[TBL] [Abstract][Full Text] [Related]
20. Daily stress and gastrointestinal symptoms in women with irritable bowel syndrome.
Hertig VL; Cain KC; Jarrett ME; Burr RL; Heitkemper MM
Nurs Res; 2007; 56(6):399-406. PubMed ID: 18004186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
